Go Pro
→ President Trump’s new AI tirade hurting GOP? (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$108.06
+0.4%		$93.01
$47.31
▼
$109.83
$4.92B0.54826,694 shs839 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.39
+0.0%		$116.93
$62.00
▼
$126.79
$4.30B0.62730,898 shs715,699 shs
LivaNova PLC stock logo
LIVN
LivaNova
$77.42
-0.5%		$80.02
$48.82
▼
$85.76
$4.27B0.87744,828 shs2,224 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$17.07
-1.0%		$19.60
$11.46
▼
$29.65
$1.19B1.551.52 million shs2.22 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
+1.78%+6.56%+2.89%+45.70%+116.33%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.15%+0.23%+1.03%+38.98%+23.10%
LivaNova PLC stock logo
LIVN
LivaNova
-0.92%-0.50%-2.59%-0.90%+42.66%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-1.71%-5.90%-27.39%+12.61%+41.46%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Haemonetics Corporation stock logo
HAE
Haemonetics
$108.06
+0.4%		$93.01
$47.31
▼
$109.83
$4.92B0.54826,694 shs839 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$126.39
+0.0%		$116.93
$62.00
▼
$126.79
$4.30B0.62730,898 shs715,699 shs
LivaNova PLC stock logo
LIVN
LivaNova
$77.42
-0.5%		$80.02
$48.82
▼
$85.76
$4.27B0.87744,828 shs2,224 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$17.07
-1.0%		$19.60
$11.46
▼
$29.65
$1.19B1.551.52 million shs2.22 million shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Haemonetics Corporation stock logo
HAE
Haemonetics
+1.78%+6.56%+2.89%+45.70%+116.33%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.15%+0.23%+1.03%+38.98%+23.10%
LivaNova PLC stock logo
LIVN
LivaNova
-0.92%-0.50%-2.59%-0.90%+42.66%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-1.71%-5.90%-27.39%+12.61%+41.46%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Haemonetics Corporation stock logo
HAE
Haemonetics
2.73
Moderate Buy$99.78-7.66% Downside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-13.08% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.55
Moderate Buy$84.138.67% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.48
Hold$29.3471.93% Upside

Current Analyst Ratings Breakdown

Latest TNDM, HAE, LIVN, and ITGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/8/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/3/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$105.00 ➝ $125.00
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $90.00
8/21/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform
8/21/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$96.00 ➝ $119.00
8/19/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$95.00 ➝ $118.00
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/18/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$96.00 ➝ $110.00
8/13/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 9/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B3.69$7.71 per share14.02$17.14 per share6.30
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.32$10.39 per share12.17$49.85 per share2.54
LivaNova PLC stock logo
LIVN
LivaNova
$1.47B2.90$4.77 per share16.23$21.98 per share3.52
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.04B1.14N/AN/A$2.29 per share7.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0452.9618.862.137.12%27.55%9.65%11/5/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.5318.842.406.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3822.9118.70N/A12.82%16.35%7.76%11/4/2026 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$0.93N/A170.66N/A-6.08%-45.97%-6.23%11/5/2026 (Estimated)

Latest TNDM, HAE, LIVN, and ITGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q1 2027
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.08$1.14+$0.06$0.72$327.86 million$339.38 million
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/6/2026Q2 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.3207-$0.31+$0.0107-$0.31$254.99 million$254.56 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Haemonetics Corporation stock logo
HAE
Haemonetics
1.40
3.08
1.91
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.62
3.18
2.65

Institutional Ownership

CompanyInstitutional Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.50 million44.56 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00034.00 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50069.58 million68.12 millionOptionable

Recent News About These Companies

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Brokerages
September 18 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-tandem-diabetes-care-inc-nasdaq-tndm-receives-consensus-rating-of-hold-from-brokerages-2026-09-18/
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
September 17 at 6:35 AM  |  zacks.comhttps://www.zacks.com/stock/news/2991045/tandem-diabetes-care-tndm-soars-7-7-is-further-upside-left-in-the-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|daily_price_change_5%-2991045
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 5.6% - Should You Buy?
September 16 at 11:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-shares-up-56-should-you-buy-2026-09-16/
Squarepoint Ops LLC Buys Shares of 217,386 Tandem Diabetes Care, Inc. $TNDM
September 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-squarepoint-ops-llc-buys-shares-of-217386-tandem-diabetes-care-inc-tndm-2026-09-13/
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 4.2% - Here's What Happened
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-stock-price-down-42-heres-what-happened-2026-09-11/
Tandem Diabetes Care: Stop Paying For Tomorrow's Profits - Strong Sell
September 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4945538-tandem-diabetes-care-stop-paying-for-tomorrows-profits-strong-sell?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued
September 10, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9076496/is-tandem-diabetes-care-inc-tndm-a-bargain-after-42-drop-gf-value-says-undervalued
First Light Asset Management LLC Boosts Position in Tandem Diabetes Care, Inc. $TNDM
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-first-light-asset-management-llc-boosts-position-in-tandem-diabetes-care-inc-tndm-2026-09-10/
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
September 9, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2987312/reasons-to-retain-tandem-diabetes-stock-in-your-portfolio-now?cid=cs-stocknewsapi-ft-analyst_blog|rank_focused-2987312
Wellington Management Group LLP Has $13.16 Million Holdings in Tandem Diabetes Care, Inc. $TNDM
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wellington-management-group-llp-has-1316-million-holdings-in-tandem-diabetes-care-inc-tndm-2026-09-08/
Tandem Diabetes Care (NASDAQ:TNDM) Share Price Passes Above 200 Day Moving Average - Here's What Happened
September 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tandem-diabetes-care-nasdaq-tndm-share-price-passes-above-200-day-moving-average-heres-what-happened-2026-09-03/
Bank of America Corp DE Has $7.16 Million Stock Position in Tandem Diabetes Care, Inc. $TNDM
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-has-716-million-stock-position-in-tandem-diabetes-care-inc-tndm-2026-08-26/
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-inc-nasdaqtndm-receives-consensus-rating-of-hold-from-analysts-2026-08-24/
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics
August 21, 2026  |  benzinga.comhttps://www.benzinga.com/analyst-stock-ratings/initiation/26/08/61363266/innovative-insulin-pumps-drive-optimism-for-tandem-beta-bionics
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/tandem-diabetes-care-maps-growth-plan-with-pharmacy-shift-and-tubeless-mobi-2026-08-18/
Tandem Diabetes Care (TNDM) Receives a Buy from Lake Street
August 16, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/3736543/tandem-diabetes-care-tndm-receives-a-buy-from-lake-street/
Oppenheimer Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)
August 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TNDM/pressreleases/3736065/oppenheimer-sticks-to-its-buy-rating-for-tandem-diabetes-care-tndm/
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973318/tndm-q2-loss-narrower-than-expected-revenues-miss-stock-up?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2973318
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
August 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/tandem-diabetes-care-buy-rating-reaffirmed-on-transformation-momentum-and-innovation-catalysts-40-price-target-maintained-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes Care Earnings Call Highlights Growth
August 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/tandem-diabetes-care-earnings-call-highlights-growth?utm_source=marketbeat.com&utm_medium=referral
Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933363-tandem-diabetes-care-inc-2026-q2-results-earnings-call-presentation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Shoppers browse folded and hanging clothing in a retail apparel store with shelves and racks displayed.
3 Retail Stocks to Watch After a Big Consumer Earnings Week
By Dan Schmidt | August 29, 2026
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
Palantir logo illuminated in a dark control room with data monitors and a U.S. Capitol building visible in the background.
Cathie Wood Trimmed Palantir, But the Bigger Story Is Still Valuation
By Sam Quirke | September 9, 2026
Haemonetics stock logo

Haemonetics NYSE:HAE

$107.92 +0.32 (+0.29%)
As of 09:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$126.40 +0.07 (+0.06%)
As of 09:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$77.45 -0.34 (-0.44%)
As of 09:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$17.04 -0.19 (-1.12%)
As of 09:39 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas